Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125283943 | 12528394 | 3 | F | 20160509 | 20160704 | 20160705 | 20160713 | EXP | PHHY2016IT089806 | SANDOZ | 80.13 | YR | M | Y | 0.00000 | 20160713 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125283943 | 12528394 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 7.5 MG, QD | 292.5 | MG | Y | 201588 | 7.5 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125283943 | 12528394 | 1 | Delusion |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125283943 | 12528394 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125283943 | 12528394 | Electrocardiogram QT prolonged | |
125283943 | 12528394 | Hyponatraemia | |
125283943 | 12528394 | Torsade de pointes |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125283943 | 12528394 | 1 | 20160401 | 20160512 | 0 |